pharma · Major Depression Disorder · Major Depression Disorders
Mylan Specialty
Mylan Pharma UK
Mylan Pharma UK is a pharma organization headquartered in CN. Primary therapeutic focus areas include Major Depression Disorder, Major Depression Disorders. NovaPharmaNews links 4 clinical program(s), 0 drug profile(s),
napa, USA HQ
233 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- napa, USA
- Employees
- 233
- Programs
- 4
- Drugs
- 10
- Patents
- 0
EPIN-IJS-1002
Phase 1 · other · Allergic reactions (Type 1), including anaphylaxis, idiopathic anaphylaxis or exercise-induced anaphylaxis
EPIN-IJS-1002 for Allergic reactions (Type 1), including anaphylaxis, idiopathic anaphylaxis or exercise-induced anaphylaxis is a Phase 1 program (other) at Mylan Pharma UK with 1 ClinicalTrials.gov record(s).
Internal code EPIN-IJS-1002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Mylan Pharma UK
- Phase
- Phase 1
- Modality
- other
- Indication
- Allergic reactions (Type 1), including anaphylaxis, idiopathic anaphylaxis or exercise-induced anaphylaxis
- Status
- active
- Trials
- 1